Oral complications of salivary hypofunction often afflict cancer patients undergoing radiotherapy for head and neck cancers. Dry mouth or xerostomia is an undesirable consequence of radiotherapy that compromises normal oral functions in addition to causing odynophagia and increasing the patient's risk of oral infections and dental caries. Radiation-induced xerostomia is irreversible, and palliative measures to provide symptomatic relief remain the mainstay of treatment. Previously, we identified a splice variant of a cellular kinase, Tousled-like kinase 1B (TLK1B), which when overexpressed protects normal epithelial cells against ionizing radiation (IR)-induced cell death. To address the need to protect salivary glands in patients undergoing regional radiotherapy, we investigated whether preemptive expression of TLK1B in salivary glands protects against IR. In stably-derived salivary cell lines in vitro, TLK1B expression increased cell survival after IR. Cells expressing exogenous TLK1B were less radiosensitive (A5-TLK1B, a/b¼0.67 Gy; ParC5-TLK1B, a/b¼4.3 Gy) compared to control cells (A5-BK, a/b¼1.7 Gy; ParC5-BK, a/b¼32.7 Gy). Using a recombinant adenovirus serotype 5 viral vector for TLK1B gene transfer into rat submandibular salivary glands in vivo, we demonstrated that TLK1B protects the saliva-secreting acinar cells and better preserves salivary gland function against IR relative to control glands. After a single fraction of 16 Gy, the decline in salivary function at 8 weeks was less pronounced in TLK1B-treated animals (40%) as compared to saline-treated controls (67%). Histopathological analysis demonstrated increase in acinar atrophy, decrease in acinar cell number, and increase in inflammatory infiltrate and fibrosis in irradiated control tissues relative to TLK1B-treated glands. These results show the radioprotective benefits of TLK1B and implicate its usefulness in the management of regional radiotherapy-induced xerostomia.
INTRODUCTION
Great strides in understanding the molecular mechanisms of carcinogenesis have helped the fight against cancer. The introduction of aggressive, multimodality treatment regimens has seen cancer survivors live longer than before. Apart from the burden of cancer, many of these patients bear the deleterious side effects of cancer treatments, some of which manifest in the oral cavity. [1] [2] [3] Oral complications afflict almost all patients undergoing radiotherapy for regional hematologic malignancies, head and neck cancers, and conditioning therapy before bone marrow transplantation. Owing to the inevitable destruction of major salivary glands that lie within the portals of radiation, the most common and distressing side effect of radiotherapy is xerostomia or dry mouth. [4] [5] [6] The reduction in salivary flow makes it difficult to perform basic oral activities, and it perpetuates the risk of oral mucositis, infections and rampant dental decay. Radiation-induced xerostomia is irreversible, and its associated morbidity compromises a patient's comfort and well-being. 7, 8 In the past, efforts were primarily geared toward symptomatic relief of post-irradiation xerostomia with artificial salivary substitutes and the use of prosecretory drugs, such as pilocarpine and cevimeline. 4, 5 Limitations to their use necessitated the development of preemptive strategies to prevent the condition rather than merely alleviate its symptoms. Salivary gland-sparing techniques (intensity-modulated radiation therapy and surgical relocation of submandibular salivary gland), and the use of the cytoprotective drug, amifostine, a free radical scavenger, have helped diminish, to some extent, the severity of radiation-induced xerostomia. 4, 9, 10 Nonetheless, the lack of appropriate treatment and the limited options to prevent xerostomia and its associated morbidity have compelled the exploration of gene therapeutics for the management of the condition. An in vivo gene therapy study involving adenoviral gene transfer of aquaporin-1 (AQP-1) has shown promise in reducing the severity of xerostomia by increasing fluid output in glands damaged by radiation. 11 In addition, a gene therapeutic that has demonstrated potential in protecting salivary gland function against ionizing radiation (IR) is manganese oxide dismutase. 12 In this study, we developed a gene transfer approach that uses the human homologue of Tousled, a chromatin-remodeling and DNA repair-associated protein, to improve cell survival and avert radiation-induced salivary gland dysfunction.
The gene Tousled of Arabidopsis thaliana encodes a protein kinase, which when mutated results in abnormalities in leaf and flower development. 13 The loss of floral and meristem organs is linked to a fault in cell division and replication. 14 Arabidopsis Tousled kinase and its homologues, Tousled-like kinases (TLKs) in human, Drosophila and Caenorhabditis elegans have generated keen interest because of their recently described roles in chromatin remodeling. [15] [16] [17] [18] A spliced variant of the human TLK1, TLK1B, was identified in our laboratory during a library screening of transcripts dependent on eukaryotic translation initiation factor 4E (eIF4E). 19 TLK1B mRNA has a long, structured 5¢ UTR (Figure 1 ), which when deleted relieves its dependence on increased eIF4E and allows its translation in normal cells. 19 The splice variant, TLK1B, is identical to the full-length TLK1 except for the exclusion of 237 N-terminal amino acids. Studies from our laboratories have demonstrated the involvement of TLK1B in genotoxic stress response and that TLK1B influences cell survival by facilitating DNA repair through its interactions with Rad9, histone H3 and histone chaperone, anti-silencing factor 1 (Asf1). 21, 22 Moreover, expression of a kinase-inactive TLK1B sensitized cells to IR, corroborating the important role of TLK1B in DNA repair and cell survival. 17, 20 Importantly, overexpression of TLK1B did not induce malignant transformation of cells or cause tumors in syngeneic animals. 19 For these reasons, we wanted to evaluate the feasibility of using TLK1B for the protection of salivary glands against IR.
RESULTS

Effect of tousled kinase on survival of rat salivary cell lines
To study the changes associated with exogenous expression of TLK1B in salivary cells, we cloned the TLK1B cDNA sequence devoid of the 5¢ UTR into an episomally replicating vector, BK-shuttle. Rat salivary gland cells, A5 and ParC5, were transfected with vector alone or BK-TLK1B plasmid, and a multiclonal population of transfected cells was enriched under G418 challenge. Salivary cells transfected with either plasmid showed no changes in cell morphology or cell doubling time when compared with parental cells (data not shown). Exposure of cells to increasing doses of IR (0 -12 Gy) demonstrated that salivary cells expressing exogenous TLK1B were more resistant to cell death after radiation (Figure 2; Supplementary Figure 1) . The difference in cell survival was marked at 4 Gy with mean survival of 73 and 69% for A5-TLK1B and ParC5-TLK1B as compared to 40.5 and 34% for vector-transfected A5-BK and ParC5-BK cells, respectively (Z-test, Pp0.05). Analyzing the relationship between cell survival and radiation dose using the linear quadratic (LQ) model, the survival curve fit yielded the following parameters: A5-BK cells: a¼0.063 Gy À1 and a/b¼1.7 Gy; A5-TLK1B: a¼0.012 Gy À1 and a/b¼0.67 Gy; ParC5-BK: a¼0.193 Gy À1 and a/b¼32.7 Gy; ParC5-TLK1B: a¼0.046 Gy À1 and a/b¼4.3 Gy (Figure 2 ). The large a/b ratio in control cells, A5-BK and ParC5-BK (Figures 2a and c) , indicate that radiation damage was dominated by the a component. Conversely, cells expressing TLK1B had an increased b component as indicated by the reduced a/b ratio (Figures 2b and d) . For comparison, the dose-response curves were fitted to the two models of the target theory, single-hit, single-target model and single-hit, multi-target model. The best survival curve fit was derived using single-hit multitarget expression, and the following radiosensitivity parameters were obtained-A5-BK: D 0 ¼2.3±0.02 Gy and n¼2.79 ± 0.04; A5-TLK1B: D 0 ¼3.42 ± 0.2 Gy and n¼3.35 ± 0.36; ParC5-BK: D 0 ¼3.31 ± 0.85 Gy and n¼1.48 ± 0.5; ParC5-TLK1B: D 0 ¼4.49±0.2 Gy and n¼2.22±0.15 (Supplementary Figure 1) . The ParC5-BK cells were most radiosensitive with cell survival following a near-exponential curve fit (Supplementary Figure 1c) . As evident by the increase in D 0 and n, the expression of TLK1B in both cells increased radioresistance (Supplementary Figures 1b and d) compared with the corresponding vector-transfected controls ( Supplementary  Figures 1a and c) .
Salivary gland-targeted adenoviral gene delivery in vivo
To assess the efficiency of in vivo retroductal gene delivery and protein expression, we transduced salivary glands with different doses of Adb-Gal (2Â10 7À10 pfu per gland). Salivary glands were excised 72 h after virus administration and frozen and paraffin sections were prepared for each salivary gland. Histological analysis of the tissues demonstrated that high doses of recombinant adenovirus (2Â10 9À10 pfu per gland) resulted in inflammation and necrosis of the gland. Widespread loss of salivary gland architecture with massive inflammatory infiltrate was evident at the highest dose, whereas focal areas of inflammation and loss of salivary components were evident even at the 10-fold lower dose of 2Â10 9 pfu per gland ( Supplementary  Figures 2a and b) . The acinar and ductal elements of the salivary glands were better preserved at doses 2Â10 8 pfu per gland and lower ( Supplementary Figures 2c and d) . Frozen sections of salivary glands reacted with X-Gal solution demonstrated efficient transduction at 2Â10 9 pfu per gland as determined by the average number of blue-stained, b-galactosidase (b-Gal)-expressing cells under Â400 high-power magnification (Table 1 ; Supplementary Figures 3b and  e) . Because the surviving population of acinar and ductal cells is reduced at high viral doses (2Â10 9À10 pfu per gland), the apparent increase in the percentage of b-Gal-stained cells at these doses is misleading (Table 1 ; Supplementary Figure 3f) . Although the transduction efficiency was lower at 2Â10 8 pfu per gland as compared to 2Â10 9 pfu per gland, the gland's secretory elements, as determined by the total number of acinar and ductal cells, were well preserved ( Table 1) .
Further optimization of gene transfer conditions was performed using Ad-TLK1B-GFP. Salivary gland transduction was assessed after delivery of different virus doses (2Â10 7À9 pfu per gland) and after delivery of virus in different infusion volumes (100-250 ml). The lowest dose of Ad-TLK1B-GFP, 2Â10 7 pfu per gland, elicited nearly 20-30% of maximal green fluorescent protein (GFP) IVIS signal counts achieved when using 2Â10 9 pfu per gland (Supplementary Figure 4a) . Near-complete gland filling was achieved at infusion volumes of 250 ml, and improved transduction corresponded well with the increase in delivery volume (Supplementary Figure 4b) . Salivary gland instilled with 100 ml volume elicited approximately half GFP IVIS signal counts as glands that received the same virus dose in a 250 ml volume. Immunoblotting of salivary gland tissue lysates with anti-serum to TLK1 confirmed TLK1B protein expression 3 days after Ad-TLK1B-GFP delivery (2Â10 8 pfu per gland; Supplementary Figure 4c ). In contrast, salivary glands infused with saline demonstrated no detectable GFP activity or TLK1B protein expression (Supplementary Figures 4a and c) . 
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Radioprotective efficacy of Tousled kinase in rat submandibular salivary glands After establishing optimal parameters for Ad-TLK1B-GFP transduction, we examined whether prophylactic expression of TLK1B in rat submandibular glands can mitigate the development of radiationinduced salivary hypofunction. Retroductal infusion of Ad-TLK1B-GFP, 2Â10 8 pfu per gland, in submandibular salivary glands was performed 3 days before exposure of animals to IR. This time period was established based on high levels of transgene expression in preliminary experiments. After exposure of animals to radiation, pilocarpine-stimulated salivary flow was analyzed as a measure of salivary function at 8 weeks after IR. Salivary flow from only the submandibular/sublingual glands was collected to avert the influence of parotid secretions on the interpretation of the results. Control animals treated with saline, but not exposed to radiation, had an average stimulated salivary flow of 428±64 ml per 20 min. Treatment of animals with saline or recombinant adenovirus alone did not appreciably influence salivary flow. However, exposure of animals to a single bolus of 16 Gy after saline instillation caused a precipitous drop in salivary flow compared to nonirradiated control animals (140 ± 11 ml per 20 min; 67% reduction). Similarly, animals pretreated with Ad-GFP demonstrated a 60% decline in salivary function after Salivary glands instilled with different doses of Ad-b-Gal (2Â10 7À10 pfu/gland) were frozen-and paraffin-processed 3 days after virus delivery (6 glands per virus dose; n¼3). Frozen sections were reacted with X-Gal solution followed by counterstaining with eosin, whereas paraffin sections were stained with hematoxylin-eosin. Blue-stained cells, indicative of b-Gal expression, were counted and compared to the total number of acinar and ductal cells in five random fields per section (Â400 magnification). Data are shown as mean ± s.d.
radiation (173±12 ml per 20 min). Most importantly, animals treated with Ad-TLK1B-GFP before exposure to IR produced saliva at the rate of 300 ± 36 ml per 20 min (Figure 3a) . These animals demonstrated a modest drop in salivary flow after IR compared to control animals and Ad-TLK1B-GFP-treated animals that did not receive radiation (30 and 40% decline in salivary flow, respectively; Figures 3a and b).
Statistical analysis of salivary flow
To determine whether treatment with TLK1B influences salivary function after IR, we used the SPSS 15.0 software (IBM Corporation, Somers, NY, USA) to statistically analyze salivary flow rate in animals pretreated, or not, with TLK1B. Half the number of animals in each treatment group were exposed to radiation. As anticipated, a two-way analysis of variance found that exposure to radiation had a significant effect on salivary flow; animals that were irradiated had lower salivary output than their nonirradiated counterparts (Po0.001). There was also a significant difference between radiation-influenced salivary flow rate for TLK1B and the controls tested; TLK1B-treated animals averaged more salivary flow than control animals that received saline alone (Po0.05).
Histopathological and immunohistochemical analysis of salivary acinar cells after IR damage Regional radiotherapy-inflicted damage compromises acinar cell function leading to a reduction in salivary flow and xerostomia. Submandibular salivary glands of untreated and treated animals were therefore analyzed for histopathological changes by hematoxylin-eosin staining 8 weeks after radiation. Irrespective of the type of pretreatment, salivary glands from nonirradiated animals showed normal histological architecture with a compact arrangement of acinar and ductal elements (Supplementary Figures 5a-c) . The histopathological findings in irradiated animals treated with saline or Ad-GFP included a loss of acinar elements, morphological changes in surviving acinar cells and inflammatory infiltrate ( Supplementary Figures 5d and e) . In contrast, salivary glands pretreated with Ad-TLK1B-GFP before exposure to IR were better preserved and were histologically more similar to nonirradiated controls (Supplementary Figure 5f) . To evaluate the fluid-secretory, acinar component of the salivary glands, we performed anti-GRP immunostaining to an acinar cell-specific protein, glutamic acid/glutamine-rich protein (GRP). As observed by histological presentation of tissues, GRP-stained acinar cells of nonirradiated salivary glands were normal in morphology irrespective of whether the glands were infused with saline or recombinant adenovirus (Supplementary Figures 6a-c) . Radiation reduced the surviving acinar cell population in control animals treated with saline or Ad-GFP ( Supplementary Figures 6d and e) . In comparison, pretreatment of salivary glands with TLK1B protected the acinar components of the glands from radiation damage (Supplementary Figure 6f) . Quantitation of percent GRP-stained acini per gland demonstrated preservation of more acinar elements after radiation in glands pretreated with Ad-TLK1B-GFP than control glands treated with saline or Ad-GFP. When compared with similarly pretreated, nonirradiated animals, modest radiation-induced decline in the acinar component was evident in Ad-TLK1B-GFP glands (22% reduction) in contrast to glands infused with saline or Ad-GFP (55 and 53% reduction, respectively; Figure 4 ). Figures 7b and c) . Salivary tissues reacted with secondary antibody alone were included as negative controls (Supplementary Figure 7a) .
In an effort to determine whether the adenoviral vector remains restricted to the salivary glands after local delivery, GFP expression was evaluated by biophotonic imaging of salivary glands and major organs such as the heart, liver, spleen and kidneys. At 3 days after recombinant virus delivery to both submandibular salivary glands (2Â10 7À9 pfu per gland), GFP IVIS signal was detected in the liver and kidneys, albeit at 25-to 45-fold lower fluorescence intensity (Supplementary Figure 8) .
DISCUSSION
Salivary hypofunction is a detrimental side effect of radiotherapy in patients treated for head and neck cancers. Despite clinical interventions to spare or shield the salivary glands from radiation, the occurrence of salivary hypofunction has remained a persistent clinical problem. [4] [5] [6] 8, 11 With no effective treatment to avert or treat the condition, palliative relief of symptoms remains the mainstay in the management of this condition. 1,4,5,9,10 Previous studies from our laboratories and that of others have indicated that TLK1B is instrumental for cell survival after genotoxic damage in 'normal' cells, 19, 20 and its expression in cancers correlates with resistance to chemotherapeutics. 23, 24 To establish whether this finding is pertinent to salivary glands in vivo, we embarked on a study aimed at determining the effect of TLK1B on radiation-affected salivary hypofunction. We report here that radioprotection conferred by exogenous expression of TLK1B in vitro is reproducible in vivo. Human TLK1B-gene transfer to rat salivary glands effectively preserved their structure and function after IR.
Tousled and its homologues are evolutionarily conserved proteins found in plants, Drosophila, C. elegans and mammals. 13, [25] [26] [27] Although Tousled-like kinases have been identified in humans, 27 and reports have demonstrated the important role of TLK1/1B in cell survival after genotoxic damage, a clear understanding of the molecular mechanism is lacking. The identification of histone H3, Asf1 and Rad9 as some of its substrates hinted at its role in chromatin remodeling and DNA repair. [19] [20] [21] [22] Recent reports have provided evidence for distinct kinase and chaperone activities of TLK1. Downregulation of TLK1 activity after DNA damage, a result of Chk1-mediated phosphorylation of TLK1 S695, suggested its possible function in checkpoint establishment. 28 However, the increased association of kinase-inactive TLK1 at DNA breaks and with Asf1 in vitro implied its function as scaffolding or chaperone protein. 29, 30 It is proposed that Rad9, a part of the 9-1-1 DNA damage-recognition complex, recruits TLK1 to DNA breaks where it alters the interaction of Asf1 with histone H3-H4 dimers to modulate chromatin and facilitate DNA repair. 21, 22 Kinase inactive TLK1 has been found in combination with a large multiprotein complex, 31 which we speculate is formed at DNA breaks by the association of TLK1 with Asf1 and other chromatin modulators and repair proteins. In light of the role of TLK1 in remodeling of chromatin at DNA breaks, it was not surprising that exogenous TLK1B expression in rat submandibular and parotid salivary cell lines increased their capacity to survive IR. These observations corroborated our previous results in mouse mammary epithelial cells, MM3MG, and they insinuated a central and critical role of TLK1/1B in resistance of epithelial cells to genotoxins.
Plasmid-liposome delivery is an attractive method of transient transgene expression. However, similar to earlier findings, 32 poor expression of transgene after liposome-mediated salivary gland gene delivery forced the exploration of viral methods of gene transfer. Recombinant adenoviral vectors efficiently infect acinar and ductal cells of rodent salivary glands, 33, 34 and our observation of efficient adenoviral-mediated gene transfer in rat salivary glands is consistent with these studies. In addition, the observation of a host response to high doses of adenovirus is in agreement with previously reported results, 35 and the ensuing tissue destruction likely accounts for the reduced number of transduced cells at high doses. However, an increase in adenovirus dose from low to moderate corresponded well with an increase in transgene expression in rat parotid glands, 36 and our results after Ad-b-Gal delivery to rat submandibular glands suggest the same. The lower adenovirus dose of 2Â10 8 pfu per gland transduced less number of salivary cells compared with glands instilled with 2Â10 9 pfu per gland. We believe that a higher number of infected cells would provide a more pronounced effect of transgene function, but with the possibility of an inflammatory reaction compounding the results, we decided to conduct all studies at the forementioned dose. Although in vitro studies provided substantial proof of the protective effect of TLK1B against IR-mediated cell death, 17, 19, 20 reports validating the same in vivo were lacking. We, therefore, investigated whether TLK1B could protect rat salivary glands and ameliorate radiationinduced hyposalivation. Salivary function was evaluated 8 weeks after radiation, a time period at which a true decline in radiation-dependent salivary flow occurs. 37, 38 Similar to previous results, 37, 38 an exposure to single dose of 16 Gy radiation precipitated a 67% drop in salivary flow in control animals. Alternatively, pretreatment with TLK1B successfully mitigated the effects of radiation on saliva production. Although endogenous TLK1B is translationally upregulated after genotoxic damage and is proposed to aid DNA repair, 39 we believe that the constitutive expression of this protein facilitates the repair process and averts apoptosis and cell death.
Penetrating IR causes DNA damage, which when not repaired pushes the cells into apoptosis or cell death. Radiotherapy regimens incorporate fractionation of dose to allow normal cells time to recover and to facilitate reoxygenation of tumors for improved tumor cell kill. Despite dose fractionation, radiation-induced acinar cell loss that begets salivary hypofunction has been reported in human 40 and rodent salivary glands. 41 The fluid-producing acinar cells of the salivary glands are sensitive to radiation, and results of our in vitro and in vivo studies are in line with this observation. A dose-dependent increase in parotid acinar cell apoptosis that is reliant on p53 was documented to occur within days following exposure of mice to IR. 42 Interestingly, mice submandibular salivary glands exposed to radiation demonstrated apoptosis of epithelial cells and fibrosis in contrast to transgenic mice expressing constitutively active Akt. 43 In our study, irradiated salivary glands of control animals demonstrated altered acinar morphology, acinar cell loss and fibrosis; changes similar to those observed in submandibular salivary glands of rats after radiation 41, 44 and of humans after chemoradiotherapy. 40 However, inflammatory infiltrate was also evident in control irradiated tissues in our study. The findings of inflammatory infiltrate and fibrous stroma are in contrast to the observations of O'Connell et al. 45 after a lower dose of IR. GRP are expressed specifically by rat acinar cells, 46 and immunostaining with antibody to GRP is often used to ascertain the acinar cell population of submandibular salivary glands. Because the salivary glands in our study were histologically evaluated at 8 weeks after radiation, we used GRP immunostaining as an indicator of surviving acinar cell population. The increased population of surviving acinar cells after radiation in TLK1B-treated glands is assumed to be related to the effect of TLK1B on repair of radiation-inflicted DNA damage. Our results provide the initial evidence that prophylactic use of TLK1B can attenuate radiation damage of salivary glands.
The accidental expression of TLK1B in malignant tumors is a valid concern. But, with most head and neck cancers showing abundant expression of eIF4E 47 and therefore, TLK1B (unpublished observations and personal communications), it is unlikely that the unintentional transduction of tumors with TLK1B will pose an added risk. However, the incorporation of salivary-specific promoters for transgene control will greatly minimize it. Regardless of localized gene delivery to encapsulated salivary glands, our results indicate that systemic spread of recombinant adenovirus remains a concern. Therefore, gene delivery with vectors that elicit a reduced host immune response as well as provide extended transgene expression will be important for the application of TLK1B in the clinical management of xerostomia where patients are treated with fractionated radiation over a period of weeks. Recombinant adeno-associated virus (AAV) for gene transfer has inherent advantages of diminished host-immune response, long-term transgene expression and the ability to transduce nondividing cells. As to salivary gland transduction, AAV appears to be the vector of choice. Previous studies demonstrated effective AAV-mediated transduction of submandibular ductal cells in mice 48 and rhesus macaques. 49 Because radioprotection of fluid-producing acinar cells is crucial to the success of TLK1B, salivary acinar cell tropisms of different AAV serotypes need to be evaluated. Nonetheless, our study using adenoviral gene transfer is the first in vivo demonstration of TLK1B-assisted protection of normal salivary cells against genotoxins such as IR.
MATERIALS AND METHODS
Cell cultures, in vitro transfections and cell radiation
Rat salivary gland cell lines, A5 and ParC5, were gifts from Dr Bruce Baum (NIDCR) and Dr David Quissell (UCHSC). A5 is a rat submandibular gland ductal epithelial cell line, whereas ParC5 is a rat parotid gland acinar cell line. Cells were propagated as described previously. 34, 50 In brief, A5 cells were grown in Dulbecco's modified Eagle's medium, whereas ParC5 in modified Dulbecco's modified Eagle's medium/F12. Media of both cell lines were supplemented with 10% bovine growth serum (Thermo Fisher Scientific, Waltham, MA, USA), 1% minimal essential amino acids (Invitrogen, Carlsbad, CA, USA) and 1% antibiotic/antimycotic solution (Invitrogen). Cells were grown at 37 1C in a humidified chamber containing 5% CO 2 . Both cell lines were grown to 60% confluence before transfections in OPTI-MEM (Invitrogen) with BK-shuttle or BK-TLK1B plasmids using GenePorter2 reagent (Genlantis, San Diego, CA, USA). The generation of BK-TLK1B plasmid has been described in Li et al. 19 Stably transformed cells were selected under geneticin (G418) challenge, and drug-resistant multiclonal populations were pooled to generate derived cell lines. The derived salivary cells exhibited similar parental cell characteristics in doubling time and cell morphology.
Salivary cells stably expressing TLK1B, or not, were detached using 0.25% trypsin-EDTA (Invitrogen) and were resuspended in medium at a density of 1Â10 5 cells per ml. Cell suspension was aliquoted in 15 ml Falcon tubes, and tubes were exposed to different doses of IR (0, 2, 4, 8 and 12 Gy). Cells were plated in triplicates at two densities in six-well plates. At 1 week after plating the cells, cell colonies were stained with crystal violet and counted.
Cloning of TLK1B and GFP in adenovirus shuttle plasmids
For cloning of TLK1B in adenovirus shuttle vector, DUALGFP-CCM (Vector BioLabs), PCR was performed to amplify TLK1B from the plasmid, KIAA0137 (a gift from Dr Takahiro Nagase, Kazusa, DNA Research Institute, Chiba, Japan), containing the full-length cDNA of human TLK1B. Primers used for PCR of TLK1B were forward primer 5¢-CAGACGGATCCCACAATGCT GAAATTAGCAGC-3¢ and reverse primer 5¢-TGCATGAATTCATTGTCCAT GATCC-3¢. Two nucleotide substitutions were incorporated to create BamHI and EcoRI restriction sites within the forward and reverse primers respectively for site-directed cloning into the shuttle vector. The PCR conditions incorporated an initial denaturation step at 94 1C for 2 min followed by 35 cycles of 94 1C for 30 s, 58 1C for 30 s, and 72 1C for 2 min. A final elongation step at 72 1C for 5 min was added before holding the tubes at 4 1C. The GFP-and b-Gal-adenoviral shuttle vectors, which harbor the cytomegalovirus enhancer/ promoter element 5¢ to the transgene cassette, were a kind gift from Dr J Michael Mathis (LSUHSC, Cell Biology and Anatomy).
Construction, propagation and characterization of recombinant adenoviral vectors
The replication-defective recombinant adenovirus vector was derived from the E1-deleted, E3-compromised adenovirus serotype 5. b-Gal, GFP cassette or a binary cassette containing TLK1B and GFP under the control of two separate cytomegalovirus promoters was inserted at the E1 deletion site. The recombinant adenoviruses were prepared and purified by CsCl centrifugations. Largescale virus preparations were conducted at the Gene Therapy Research Core Facility at the institution. For large-scale virus preparations, 80% confluent HEK293 cells were infected with the adenovirus stock at a multiplicity of infection of 100, and the virus was purified using the Adenopure LS adenovirus purification kit (Puresyn, Malvern, PA, USA) as per the manufacturer's instructions. Virus titers were calculated by UV spectrometry (A260) and by plaque assay. The ratio of viral particles to plaque-forming units for Ad-b-Gal preparation was 60:1 particles per pfu, whereas for Ad-GFP and Ad-TLK1B-GFP preparations the ratio was B100:1 particles per pfu. The adenoviruses were syringe filtered and stored at À70 1C in phosphate-buffered saline (PBS, pH 7.4), containing 5% glycerol.
In vivo infusion of adenovirus, IVIS imaging and exposure of animals to ionizing radiation
Male, 3-month-old Wistar rats weighing 250-275 g were grouped, weighed and anesthetized using a mix of ketamine chloride (42 mg kg À1 body weight (BW)), xylazine (8 mg kg À1 BW) and acepromazine (1.4 mg kg À1 BW). Atropine (0.5 mg kg À1 BW) was administered subcutaneously before retroductal delivery of saline or recombinant adenovirus, Ad-b-Gal, Ad-GFP or Ad-TLK1B-GFP, into each submandibular salivary gland. The polyethylene tubing in the cannulated salivary ducts was retained for 30 min after viral delivery. Animals were kept warm during recovery, and housed in a light-and temperaturecontrolled environment after they were ambulatory.
At 3 days after virus infusion, animals were weighed, anesthetized and either killed to evaluate adenovirus transduction efficiency (n¼3) or exposed to IR to monitor the effects of radiation on salivary flow (n¼6). Adenoviral transduction efficiency was also determined by evaluating b-Gal activity in salivary glands transduced with different doses of Ad-b-Gal (n¼3). Half of each salivary gland was fixed in 4% cold paraformaldehyde and processed for paraffin embedding and sectioning, whereas the other half was fixed in 2% formaldehyde, 0.2% glutaraldehyde in PBS (pH 7.4) and embedded in OCT compound (Tissue-Tek). Frozen sections were fixed in formaldehyde/glutaraldehyde fixative and reacted with X-gal (0.5 mg ml À1 ) in PBS (pH 7.4) containing 5 mM K 4 Fe(CN) 6 , 5 mM K 3 Fe(CN) 6 , 2 mM MgCl 2 at 4 1C for 16 h. Tissue sections were washed and counterstained with eosin. Cells that stained blue were counted in five random fields per gland at Â400 high-power magnification. Paraffin sections were stained with hematoxylin-eosin for histopathological analysis, and nuclei of acinar and ductal elements were counted in five fields under the same magnification (Â400) to determine the percentage of b-Galtransduced cells.
Using Xenon IVIS 100/XFO-12 apparatus, we evaluated recombinant adenovirus transduction efficiency and vector biodistribution by biophotonic GFP imaging of Ad-TLK1B-GFP-treated animals. Region of interest counts were determined using Living Image 3.2 software (Caliper Life Sciences, Hopkinton, MA, USA). Immunoblotting for TLK1B protein was performed to confirm expression of the protein. The salivary tissue was sonicated in RIPA buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.1 mM TLK1 and radioprotection of salivary glands S Palaniyandi et al phenylmethylsulfonyl fluoride), and 30 mg of clarified lysate protein was electrophoresed on 10% SDS-polyacrylamide gels. The proteins were blotted on to nitrocellulose and probed with antiserum to TLK1. 19 Anesthetized animals to be radiated were placed in a supine position, and the radiation field was collimated to the region from the lower border of the mandible to the upper border of the thoracic cage. Animals were exposed to a single dose of 16 Gy at 6 MV using the Elekla RTD with MLC Linear Accelerator (LSUHSC, Radiation Oncology). This radiation dose is biologically nearequivalent to the fractionated dose of 16Â2 Gy. 41 Megavoltage photons generated by linear accelerators penetrate 2-4 cm into the tissue before reaching maximum dose and organs near the skin do not receive adequate irradiation. Therefore, mimicking clinical regimens, a 1 cm tissue-equivalent bolus was placed on the supine neck of the animal to achieve maximal radiation dose closer to the anticipated plane of the submandibular salivary glands. The use of a tissue-equivalent bolus and the collimation of the radiation beam to the area of interest potentially reduced the side effects of radiation on other tissues and on the general health of the animals. After radiation, animals were allowed to recover from anesthesia before housing them separately with free access to water and feed. Animals were checked daily for any signs of distress. All experiments were performed as described in the protocol approved by the LSUHSC Animal Care and Use Committee, and they conformed to the guidelines for the care and use of laboratory animals.
Submandibular gland saliva collection
Submandibular salivary secretions were collected and measured 8 weeks after IR. Animals were anesthetized as described before, and secretory flow was induced by subcutaneous administration of pilocarpine (0.5 mg kg À1 ). Cotton rolls were placed in each buccal pouch and at the rear of the mouth to avoid collecting parotid gland secretions. Within 5 min of pilocarpine administration submandibular salivary flow was evident at the floor of the mouth. Welled up saliva was aspirated using a thin plastic tubing and collected in microcentrifuge tubes. Saliva was collected for 20 min, measured and salivary flow rates were determined.
Histology and immunohistochemistry of salivary glands
After collection of saliva, animals were killed under anesthesia by cardiac perfusion of cold 4% paraformaldehyde in PBS. Submandibular salivary glands were excised and fixed for 8 h in paraformaldehyde-PBS (4%). The tissue was then paraffin embedded or transferred to 30% sucrose in PBS for 8 h before embedding in Tissue-Tek O.C.T. compound (Sakura Finetek, Torrance, CA, USA). Paraffin sections were stained with hematoxylin-eosin, and frozen sections were processed for immunostaining using anti-GRP (1:300), a gift from Dr Lawrence Tabak (NIDCR), or anti-GFP (1:300; Invitrogen). Sections were incubated in primary antibody for 1 h at room temperature followed by Biogenex horseradish peroxidase-conjugated universal secondary antibody for 30 min. Tissue sections were incubated with diaminobenzidine for 2 min, and cytoplasmic staining for GRP or GFP was evaluated. Salivary tissues reacted with secondary antibody alone were included as negative controls for immunohistochemical staining.
